Research Article
Diagnostic Value of Serum Markers Combined with TVCDS in Ovarian Cancer Patients Treated with Bushen Yiqi Quyu Prescription
Table 1
Comparison of general clinical data between the two groups.
| | Observation group (n = 116) | Control group (n = 116) | X2 | |
| Age (years) | | | 0.075 | 0.784 | >50 | 74 | 76 | | | ≤50 | 42 | 40 | | | Weight (kg) | | | 0.163 | 0.687 | >62 | 69 | 72 | | | ≤62 | 47 | 44 | | | The course of OC (years) | | | 0.309 | 0.578 | >2 | 37 | 41 | | | ≤2 | 79 | 75 | | | Symptom | | | 0.086 | 0.769 | Obvious abdominal pain | 83 | 85 | | | No obvious symptoms | 33 | 31 | | | Clinical stage | | | 0.177 | 0.981 | I | 27 | 29 | | | II | 35 | 34 | | | III | 43 | 41 | | | IV | 11 | 12 | | | Pathological type | | | 0.395 | 0.941 | Serous cystadenocarcinoma | 78 | 75 | | | Endometrial carcinoma | 7 | 6 | | | Mucinous cystadenocarcinoma | 19 | 22 | | | Others | 12 | 13 | | |
|
|